Skip to main content
. 2015 Oct 14;172(20):4959–4969. doi: 10.1111/bph.13265

Figure 5.

Figure 5

ERK1/2 inhibition reduces angiotensin (ANG) II‐induced vasoconstriction and altered responses to NECA in MAs from WT mice. (A) PD98059 (1 μM), an ERK1/2 inhibitor, significantly reduced ANG II (10 nM)‐induced vasoconstrictions (control n = 10, PD98059 n= 6; *P < 0.05 compared with control). (B) Altered response to NECA after ANG II stimulation was also blocked by PD98059. *P < 0.05 compared with control NECA response, and #P < 0.05 compared with response after PD98059 treatment.